BRIEF-Normunity Closes $75 Million Series B Financing To Advance Lead Drug Program
ReutersJan 13, 2025 11:24 AM
Jan 13 (Reuters) - Pfizer Inc PFE.N:
NORMUNITY CLOSES $75 MILLION SERIES B FINANCING TO ADVANCE LEAD DRUG PROGRAM INTO THE CLINIC AND BROADEN PIPELINE OF NOVEL ANTI-CANCER THERAPIES TARGETING UNTAPPED DRUG MECHANISMS
FINANCING CO-LED BY SAMSARA BIOCAPITAL, ENAVATE SCIENCES, WITH PFIZER VENTURES AND REGENERON VENTURES & OTHER NEW, EXISTING INVESTORS
Source text: ID:nBw8n3Q7wa
Further company coverage: PFE.N
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
What Are Meme Coins? From DOGE to SHIB, PEPE to PENGU — The Hype, the Culture, and the Risk
Meme coins are cryptocurrencies inspired by internet culture — often humorous, ironic, or satirical in nature. Unlike Bitcoin (BTC) or Ethereum (ETH), which aim to solve technical or financial problems, meme coins thrive on community hype, viral storytelling, and low entry barriers.TradingKey
6 hours ago
Investing in Robotics Stocks
TradingKey - Robotics has graduated from being a specialized technical innovation to one of the most powerful enablers of productivity in today's economy. Robots are no longer restricted to auto plants and lab coats and now operate across sectors, healthcare and agriculture as well as logistics...TradingKey
7 hours ago
AMD Q2 FY2025 Earnings Review: Impressive Growth Stumbles on Export Control Hurdles
TradingKey - Advanced Micro Devices, Inc. (NASDAQ: AMD) released its Q2 FY2025 earnings on August 5, 2025, after market close, delivering robust results driven by record sales in its Data Center and Client segments. Despite a 32% YoY revenue increase, surpassing expectations, the stock dipped aroundTradingKey
11 hours ago
